Interactions between PD-1 and its ligand PD-L1 leads to inhibition of the adaptive and innate arms of the immune system and is a well-described mechanism behind tumor evasion, and suppression of the anti-cancer immune response. The gene discussed is CD274; the disease is neoplasm.